Skip to main content
Clinical Trials/CTRI/2022/04/042194
CTRI/2022/04/042194
Completed
Phase 2

A Comparative Study to evaluate the efficacy of Patha Vidanga Arjuna Dhanvana Kwath with conventional medicine alone in control of â??Metabolic Syndromeâ?? in Urban Population of an area in an Urbanised Indian State

Dhanwantarikumar Harinath Jha0 sites140 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dhanwantarikumar Harinath Jha
Enrollment
140
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dhanwantarikumar Harinath Jha

Eligibility Criteria

Inclusion Criteria

  • o Age 40\-65 Yrs.
  • o Patients with Metabolic syndrome according to NCEP ATP3 Criteria.

Exclusion Criteria

  • 1\) Age \<40yrs. and \>65yrs.
  • 2\) With associated heart disease or other secondary complications.

Outcomes

Primary Outcomes

Not specified

Similar Trials